Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

CannaSafety

CannaSafety
2015 FOUNDED
PRIVATE STATUS
Series A LATEST DEAL TYPE
Description

Developer of Cannabis antidote designed to help relieve the negative effects of consuming too much cannabis. The company's product CannaRelief has been specifically formulated with ingredients that reduce anxiety and negative effects of consuming too much cannabis and features a proprietary blend of herbs, vitamins, amino acids and CO2 extracted CBD oil from hemp seed and stalk and works equally well in conjunction with flowers, edibles and concentrates, enabling beginners, adventurous users and also medical patients to avoid the feeling of uncomfortable or anxiousness.

Ownership Status
Privately Held (backing)
Financing Status
Angel-Backed
Primary Industry
Other Pharmaceuticals and Biotechnology
Other Industries
Other Healthcare
Primary Office
  • 215 South Conklin Road
  • Unit B-8
  • Spokane Valley, WA 99037
  • United States
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore CannaSafety’s full profile, request a free trial.

CannaSafety Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Angel (individual) Completed Generating Revenue
To view this company’s complete deal history including valuation and funding, request access »

CannaSafety Executive Team (2)

Name Title Board
Seat
Contact
Info
William Brouillet Chief Executive Officer & Chief Operating Officer
Tom Lindeman Founder